Mutational spectrum of β-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas
暂无分享,去创建一个
David I. Smith | Xiangyang Dong | D. Nagorney | L. Roberts | L. Burgart | P. Roche | J. Ross | I. Aderca | Julie A Ross | Patrick C Roche | Lewis R Roberts | Ken Taniguchi | David M Nagorney | Wanguo Liu | Lawrence J Burgart | Chiping Qian | David I Smith | Wanguo Liu | Xiang-yang Dong | K. Taniguchi | C. Qian | Linda M Murphy | Ileana N Aderca | Linda M. Murphy | Ileana Aderca
[1] M. Matsuda,et al. β-Catenin Mutations Are Frequent in Human Hepatocellular Carcinomas Associated with Hepatitis C Virus Infection , 1999 .
[2] W. Birchmeier,et al. Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta. , 1998, Science.
[3] Michael Kühl,et al. Functional interaction of β-catenin with the transcription factor LEF-1 , 1996, Nature.
[4] S. Hirohashi,et al. β‐Catenin Accumulation and Mutation of Exon 3 of the β‐Catenin Gene in Hepatocellular Carcinoma , 1999, Japanese journal of cancer research : Gann.
[5] J. Wands,et al. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa , 1991, Nature.
[6] S N Thibodeau,et al. Denaturing high performance liquid chromatography (DHPLC) used in the detection of germline and somatic mutations. , 1998, Nucleic acids research.
[7] Kathleen R. Cho,et al. Diverse mechanisms of beta-catenin deregulation in ovarian endometrioid adenocarcinomas. , 2001, Cancer research.
[8] Y. Jeng,et al. Expression of mutant nuclear β‐catenin correlates with non‐invasive hepatocellular carcinoma, absence of portal vein spread, and good prognosis , 2001, The Journal of pathology.
[9] S. Albrecht,et al. Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the beta-catenin gene. , 1999, Cancer research.
[10] A. Millar,et al. Beta-catenin mutations are specific for colorectal carcinomas with microsatellite instability but occur in endometrial carcinomas irrespective of mutator pathway. , 1999, Cancer research.
[11] J. Ferlay,et al. Globocan 2000 : cancer incidence, mortality and prevalence worldwide , 2001 .
[12] M. Buendia. Genetics of hepatocellular carcinoma. , 2000, Seminars in cancer biology.
[13] Hans Clevers,et al. Negative Feedback Loop of Wnt Signaling through Upregulation of Conductin/Axin2 in Colorectal and Liver Tumors , 2002, Molecular and Cellular Biology.
[14] W. Liu,et al. Cloning of the human homolog of conductin (AXIN2), a gene mapping to chromosome 17q23-q24. , 1999, Genomics.
[15] Y. Shiratori,et al. Activation of intracellular signaling by hepatitis B and C viruses: C‐viral core is the most potent signal inducer , 2000, Hepatology.
[16] M. Makuuchi,et al. Molecular basis of multistep hepatocarcinogenesis: genetic and epigenetic events. , 1999, Scandinavian journal of gastroenterology.
[17] Choun-Ki Joo,et al. Wnt/β-Catenin/Tcf Signaling Induces the Transcription of Axin2, a Negative Regulator of the Signaling Pathway , 2002, Molecular and Cellular Biology.
[18] Mark Peifer,et al. β-Catenin as Oncogene--The Smoking Gun , 1997, Science.
[19] G. Thomas,et al. Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis. , 2001, Gastroenterology.
[20] M. Buendia,et al. Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[21] Y. Jeng,et al. Beta-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis. , 2000, The American journal of pathology.
[22] Wei Hsu,et al. The Mouse Fused Locus Encodes Axin, an Inhibitor of the Wnt Signaling Pathway That Regulates Embryonic Axis Formation , 1997, Cell.
[23] M. Wiesmann,et al. Elevated expression of axin2 and hnkd mRNA provides evidence that Wnt/β-catenin signaling is activated in human colon tumors , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[24] Yusuke Nakamura,et al. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1 , 2000, Nature Genetics.
[25] Y. Jeng,et al. Somatic mutations of beta-catenin play a crucial role in the tumorigenesis of sporadic hepatoblastoma. , 2000, Cancer letters.
[26] B. Raney. Hepatoblastoma in Children: A Review , 1997, Journal of pediatric hematology/oncology.
[27] David I. Smith,et al. Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating β-catenin/TCF signalling , 2000, Nature Genetics.
[28] W. Liu,et al. Genomic structure, chromosome mapping and expression analysis of the human AXIN2 gene , 2001, Cytogenetic and Genome Research.
[29] G. G. Stokes. "J." , 1890, The New Yale Book of Quotations.